Individual Early Warning Score (I-EWS)
Launched by HERLEV HOSPITAL · Sep 27, 2018
Trial Information
Current as of October 04, 2025
Completed
Keywords
ClinConnect Summary
Every year more than 250,000 patients are admitted in the Capital Region of Denmark. During admissions, the clinical track and trigger system "Early Warning Score" (EWS) is used to systematically observe and detect acutely deteriorating patients. The system is designed to prevent serious adverse events like unanticipated transfer to the intensive care unit, cardiac arrest and unexpected death. EWS consists of standardized measurements of the patient's vital signs and an escalation protocol that determines further actions based on the aggregated EWS score. At admission, and as a minimum twic...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients ≥18 years of age admitted more than 24 hours to a ward at participating hospitals will be included.
- • Participating hospitals are
- • Herlev \& Gentofte Hospital
- • Nordsjaellands Hospital
- • Bispebjerg Hospital
- • Rigshospitalet, Glostrup - Medical Ward
- • Amager \& Hvidovre Hospital
- • Zealand University Hospital
- • Slagelse Hospital
- • Holbaek Hospital
- Exclusion Criteria:
- • Wards not using standard EWS, paediatric, obstetric and intensive, due to they use special variations (Pediatric early warning score, Obstetric Early warning Score or continous monitoring).
About Herlev Hospital
Herlev Hospital, a leading healthcare institution located in Denmark, is dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. As a key player in the Danish healthcare system, Herlev Hospital combines cutting-edge facilities with a multidisciplinary approach to research, fostering collaborations among healthcare professionals and researchers. The hospital focuses on a wide range of medical fields, aiming to enhance treatment efficacy and patient care through rigorous scientific inquiry and ethical standards. With a commitment to excellence, Herlev Hospital plays a pivotal role in translating clinical research findings into practical applications that benefit patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Copenhagen, Capital Region Of Denmark, Denmark
Copenhagen, Capital Region Of Denmark, Denmark
Copenhagen, Capital Region Of Denmark, Denmark
Glostrup, Capital Region Of Denmark, Denmark
Hillerød, Capital Region Of Denmark, Denmark
Holbæk, Region Of Zealand, Denmark
Roskilde, Region Of Zealand, Denmark
Slagelse, Region Of Zealand, Denmark
Patients applied
Trial Officials
Kasper Iversen, MD, DMSci
Study Director
Department of Cardiology, Herlev Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials